The effects of cell therapy on heart regeneration in patients with chronic cardiomyopathy
have been assessed in several clinical trials. These trials can be categorized as those using …

The retraction of> 30 falsified studies by Anversa et al. has had a disheartening impact on
the cardiac cell therapeutics field. The premise of heart muscle regeneration by the …

Sixty-nine patients who underwent primary percutaneous coronary intervention within 12
hours after onset of acute myocardial infarction were randomized to receive intracoronary …

Is there any reason to write a third book on the topic of oxygen-ozone therapy? The first was
written four years ago for italian physicians, who, for some time, had complained about the …

Mesenchymal stem cell (MSC) is an intensely studied stem cell type applied for cardiac
repair. For decades, the preclinical researches on animal model and clinical trials have …

Stem cells have the potential to differentiate into cardiovascular cell lineages and to
stimulate tissue regeneration in a paracrine/autocrine manner; thus, they have been …

Recent studies suggest that the intracoronary administration of bone marrow (BM)-derived
mesenchymal stem cells (MSCs) may improve left ventricular function in patients with acute …

Aims Despite accumulated evidence that intracoronary bone marrow cell (BMC) therapy
may be beneficial in acute myocardial infarction, there are only limited data available on the …

Recent evidence has demonstrated the importance of bone marrow-derived mesenchymal
stem cells (BM-MSCs) in the repair of damaged myocardium. The molecular mechanisms of …

Introduction Stem cell therapy has emerged as a promising strategy for the treatment of
ischemic cardiomyopathy. Sources of data Multiple candidate cell types have been used in …